Impairment of oil and gas properties; is a ceiling test needed for successful efforts companies? von Pariser, David G, Titard, Pierre L

Volltext

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis von Armstrong, April W., MD, MPH, Siegel, Michael P., PhD, Bagel, Jerry, MD, Boh, Erin E., MD, PhD, Buell, Megan, Cooper, Kevin D., MD, Callis Duffin, Kristina, MD, MS, Eichenfield, Lawrence F., MD, Garg, Amit, MD, Gelfand, Joel M., MD, MSCE, Gottlieb, Alice B., MD, PhD, Koo, John Y.M., MD, Korman, Neil J., MD, PhD, Krueger, Gerald G., MD, Lebwohl, Mark G., MD, Leonardi, Craig L., MD, Mandelin, Arthur M., MD, PhD, Menter, M. Alan, MD, Merola, Joseph F., MD, MMSC, Pariser, David M., MD, Prussick, Ronald B., MD, FRCP, Ryan, Caitriona, MD, Shah, Kara N., MD, Weinberg, Jeffrey M., MD, Williams, MaryJane O.U., MD, Wu, Jashin J., MD, Yamauchi, Paul S., MD, PhD, Van Voorhees, Abby S., MD

Volltext

Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis von Paller, Amy S., MD, Siegfried, Elaine C., MD, Pariser, David M., MD, Rice, Kara Creamer, MS, Trivedi, Mona, MD, Iles, Jan, MD, Collier, David H., MD, Kricorian, Greg, MD, Langley, Richard G., MD

Volltext

A framework for the investigation of rare genetic disorders in neuropsychiatry von Sanders, Stephan J., Sahin, Mustafa, Hostyk, Joseph, Thurm, Audrey, Jacquemont, Sebastien, Avillach, Paul, Douard, Elise, Martin, Christa L., Modi, Meera E., Moreno-De-Luca, Andres, Raznahan, Armin, Anticevic, Alan, Dolmetsch, Ricardo, Feng, Guoping, Geschwind, Daniel H., Glahn, David C., Goldstein, David B., Ledbetter, David H., Mulle, Jennifer G., Pasca, Sergiu P., Samaco, Rodney, Sebat, Jonathan, Pariser, Anne, Lehner, Thomas, Gur, Raquel E., Bearden, Carrie E.

Volltext

Topical 0.5% Ivermectin Lotion for Treatment of Head Lice von Pariser, David M, Meinking, Terri Lynn, Bell, Margie, Ryan, William G

Volltext

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials von Lebwohl, Mark G, Kircik, Leon H, Moore, Angela Y, Stein Gold, Linda, Draelos, Zoe D, Gooderham, Melinda J, Papp, Kim A, Bagel, Jerry, Bhatia, Neal, Del Rosso, James Q, Ferris, Laura K, Green, Lawrence J, Hebert, Adelaide A, Jones, Terry, Kempers, Steven E, Pariser, David M, Yamauchi, Paul S, Zirwas, Matthew, Albrecht, Lorne, Devani, Alim R, Lomaga, Mark, Feng, Amy, Snyder, Scott, Burnett, Patrick, Higham, Robert C, Berk, David R

Volltext

Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials von Gold, Linda Stein, Lebwohl, Mark G., Sugarman, Jeffrey L., Pariser, David M., Lin, Tina, Martin, Gina, Pillai, Radhakrishnan, Israel, Robert, Ramakrishna, Tage

Volltext

Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial von Draelos, Zoe D, Adam, David N, Hong, H Chih-Ho, Lebwohl, Mark G, Lynde, Charles W, Nahm, Walter K, Papp, Kim A, Pariser, David M, Stein Gold, Linda, Stewart, Daniel, Higham, Robert C, Berk, David R, Krupa, David, Burnett, Patrick

Volltext

Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis von Lebwohl, Mark G., Sugarman, Jeffrey L., Gold, Linda Stein, Pariser, David M., Lin, Tina, Pillai, Radhakrishnan, Martin, Gina, Harris, Susan, Israel, Robert

Volltext

Trial of Roflumilast Cream for Chronic Plaque Psoriasis von Lebwohl, Mark G, Papp, Kim A, Stein Gold, Linda, Gooderham, Melinda J, Kircik, Leon H, Draelos, Zoe D, Kempers, Steven E, Zirwas, Mathew, Smith, Kathleen, Osborne, David W, Trotman, Marie-Louise, Navale, Lynn, Merritt, Charlotte, Berk, David R, Welgus, Howard

Volltext

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials von Griffiths, Christopher E M, Prof, Reich, Kristian, Prof, Lebwohl, Mark, Prof, van de Kerkhof, Peter, Prof, Paul, Carle, Prof, Menter, Alan, MD, Cameron, Gregory S, PhD, Erickson, Janelle, PhD, Zhang, Lu, MS, Secrest, Roberta J, PhD, Ball, Susan, PhD, Braun, Daniel K, MD, Osuntokun, Olawale O, MD, Heffernan, Michael P, MD, Nickoloff, Brian J, MD, Papp, Kim, MD

Volltext

Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study von Blauvelt, Andrew, Pariser, David M., Tyring, Stephen, Bagel, Jerry, Alexis, Andrew F., Soung, Jennifer, Armstrong, April W., Muscianisi, Elisa, Kianifard, Farid, Steadman, Jennifer, Sarkar, Rajendra Prasad, Garcet, Sandra, Krueger, James G.

Volltext

Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial von Stein Gold, Linda, Alonso-Llamazares, Javier, Draelos, Zoe D., Gooderham, Melinda J., Kempers, Steven E., Kircik, Leon H., Lebwohl, Mark G., Papp, Kim A., Pariser, David M., Toth, Darryl P., Yosipovitch, Gil, Higham, Robert C., Feng, Amy, Berk, David R.

Volltext

Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR von Bissonnette, Robert, Gottlieb, Alice B., Langley, Richard G., Leonardi, Craig L., Papp, Kim A., Pariser, David M., Uy, Jonathan, Lafferty, Kim Parnell, Langholff, Wayne, Fakharzadeh, Steven, Berlin, Jesse A., Brouwer, Emily S., Greenspan, Andrew J., Strober, Bruce E.

Volltext

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, doubl... von Papp, K., Gottlieb, A., Reich, K., Maari, C., Gordon, K.B., Lima, R.G., Elmaraghy, H., Gallo, G., Renda, L., Park, S.Y., Burge, R., Bagel, J., Vender, Ronald, Hong, Chih‐Ho, Langley, Richard L., Albrecht, Lorne, Guenther, Lyn, Papp, Kim, Singh Ohson, Kamal K., Barber, Kirk, Lynde, Charles, Gupta, Aditya, Rosoph, Leslie, Gauthier, Jean‐Sébastien, Gooderham, Melinda, Wasel, Norman, Wiseman, Marni, Greenstein, David, Jarell, Abel, Moon, Charles, Bukhalo, Michael, Moore, Angela, Hamilton, Tiffani K., Gewirtzman, Aron, Hazan, Lydie, Crowley, Jeffrey, Teller, Craig, Smith, Stacy R., Christine Lee, M., Lee, Patricia, Dhawan, Sunil, Leonardi, Craig, Jesus, Amarilis Perez‐De, McFalda, Wendy, Fretzin, Scott, Schlesinger, Todd, Gottlieb, Scott, Jenkin, Peter, Gharib, Rola, Davis, Steven, Draelos, Zoe Diana, Godwin, Lloyd, Landis, Megan, Sanchez‐Rivera, Samuel, Fivenson, David, Kerdel, Francisco, Forman, Seth B., Gonzalez‐Chavez, Jose, Boyce, Brent, Stein‐Gold, Linda, Hudson, Charles, Brown, Constance, Coggi, James, Feser, Christina, McCune, Mark, Madkan, Vandana, Shipp, Dana Maxwell, Soto‐Raices, Oscar, Cather, Jennifer, Miller, Scott, Scott, John, Young, Douglas, Yokum, Kelley, McCracken, Gary, McElgunn, Patrick, Herrmann, James, Appel, James, Barranco, Elizabeth, Cauthen, Ashley, Sadick, Neil, De La Torre, Eneida, Taylor, Kelly, Harris, Holly Hake, Soung, Jennifer, Dimitropoulos, Vassilios, Miller, Stephen, Barnes, Cathy, Jumean‐Haddad, Rawan, Guenthner, Scott, Laquer, Vivian, Jacobs, Shahram, Nahm, Walter, Korman, Neil, Elewski, Boni, Ferris, Laura, Duffin, Kristina Callis, Pariser, David, Johnson, Brian, Travers, Jeffrey, Fried, Richard

Volltext

Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis von Simpson, Eric, Eckert, Laurent, Gadkari, Abhijit, Mallya, Usha G, Yang, Min, Nelson, Lauren, Brown, Michelle, Reaney, Matt, Mahajan, Puneet, Guillemin, Isabelle, Boguniewicz, Mark, Pariser, David

Volltext

Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate von Packiam, Vignesh T, Patel, Sanjay G, Pariser, Joseph J, Richards, Kyle A, Weiner, Adam B, Paner, Gladell P, VanderWeele, David J, Zagaja, Gregory P, Eggener, Scott E

Volltext

Long-term etanercept in pediatric patients with plaque psoriasis von Paller, Amy S., MD, Siegfried, Elaine C., MD, Eichenfield, Lawrence F., MD, Pariser, David, MD, Langley, Richard G., MD, Creamer, Kara, MS, Kricorian, Greg, MD

Volltext

The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score von Papp, Kim A., Lebwohl, Mark G., Kircik, Leon H., Pariser, David M., Strober, Bruce, Krueger, Gerald G., Berk, David R., Navale, Lynn, Higham, Robert C.

Volltext

From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis von Lebwohl, Mark, MD, Bagel, Jerry, MD, Gelfand, Joel M., MD, MSCE, Gladman, Dafna, MD, Gordon, Kenneth B., MD, Hsu, Sylvia, MD, Kalb, Robert E., MD, Kimball, Alexa Boer, MD, MPH, Korman, Neil J., MD, PhD, Krueger, Gerald G., MD, Mease, Philip, MD, Morison, Warwick L., MD, Paller, Amy, MD, Pariser, David M., MD, Ritchlin, Christopher, MD, Strober, Bruce, MD, PhD, Van Voorhees, Abby, MD, Weinstein, Gerald D., MD, Young, Melodie, MSN, RN, Horn, Liz, PhD

Volltext